(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -29.08%-1.57M | -95.12%-1.28M | 33.57%-5.1M | -155.02%-1.76M | 32.33%-1.47M | 47.86%-1.21M | 73.59%-655.47K | 15.49%-7.67M | 75.79%-688.62K | 22.70%-2.18M |
Net income from continuing operations | -55.71%-1.87M | -51.28%-1.56M | 110.87%1.12M | -114.09%-2.05M | 376.16%5.41M | 69.58%-1.2M | 70.30%-1.03M | 7.66%-10.35M | 72.60%-957.9K | 44.48%-1.96M |
Operating gains losses | 269.42%104.69K | -79.96%-104.32K | -6,049.77%-6.34M | -21.45%26.28K | -27,036.50%-6.24M | -154.80%-61.8K | -246.79%-57.97K | 231.23%106.51K | -28.07%33.46K | 61.76%-23.01K |
Depreciation and amortization | -16.73%137.52K | 5.88%170.43K | 4.28%656.81K | 2.47%165.42K | 5.71%165.28K | 0.32%165.14K | 9.15%160.97K | 69.15%629.87K | 28.68%161.44K | 52.37%156.35K |
Asset impairment expenditure | ---- | ---- | --125.14K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Remuneration paid in stock | -1.32%59.33K | 35.70%126.32K | -56.03%390.34K | 62.23%192.36K | -76.26%44.77K | -74.29%60.12K | -73.15%93.08K | -43.40%887.69K | -73.29%118.58K | -66.85%188.56K |
Other non cashItems | ---- | ---- | 2,399.08%100.03K | --15.39K | --23.25K | --31.91K | --29.48K | ---4.35K | ---- | ---- |
Change In working capital | 101.43%2.97K | -39.74%91.74K | -209.81%-1.16M | -477.09%-229.98K | -61.99%-872.24K | -118.65%-207.35K | -70.75%152.24K | 296.61%1.05M | -212.50%-39.85K | -623.23%-538.44K |
-Change in receivables | -400.10%-26.28K | 32.63%-1.69K | -400.05%-6.51K | -106.81%-915 | 157.48%2.16K | 64.22%-5.25K | -134.87%-2.5K | 109.78%2.17K | 910.86%13.44K | 77.85%-3.76K |
-Change in prepaid assets | -83.23%-25.27K | 90.69%-966 | -142.01%-75.32K | -127.37%-12.43K | -364.14%-38.73K | -144.48%-13.79K | -111.76%-10.38K | 252.84%179.27K | -45.01%45.41K | 108.89%14.66K |
-Change in payables and accrued expense | 131.04%50.17K | -9.55%96.25K | -228.17%-917.7K | -30.49%-216.82K | -10.73%-645.69K | -115.31%-161.61K | -74.01%106.41K | 72.80%716.01K | -357.09%-166.16K | -304.75%-583.11K |
-Change in other current liabilities | 116.29%4.35K | -103.15%-1.85K | -200.86%-157.79K | -99.73%182 | -662.68%-189.99K | -167.46%-26.7K | 275.03%58.71K | 1,810.20%156.45K | --67.46K | --33.77K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -29.08%-1.57M | -95.12%-1.28M | 33.57%-5.1M | -155.02%-1.76M | 32.33%-1.47M | 47.86%-1.21M | 73.59%-655.47K | 15.49%-7.67M | 75.79%-688.62K | 22.70%-2.18M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -81.82%-89.65K | -149.34%-290.76K | 44.17%-343.93K | -18.56%-55.98K | -801.17%-122.03K | 59.63%-49.31K | 73.07%-116.61K | 70.14%-615.99K | 93.60%-47.22K | 98.04%-13.54K |
Net PPE purchase and sale | -81.82%-89.65K | -149.34%-290.76K | 44.17%-343.93K | -18.56%-55.98K | -801.17%-122.03K | 59.63%-49.31K | 73.07%-116.61K | 70.14%-615.99K | 93.60%-47.22K | 98.04%-13.54K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -81.82%-89.65K | -149.34%-290.76K | 44.17%-343.93K | -18.56%-55.98K | -801.17%-122.03K | 59.63%-49.31K | 73.07%-116.61K | 70.14%-615.99K | 93.60%-47.22K | 98.04%-13.54K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 36,713.11%2.27M | -99.12%24.25K | 68.49%7.98M | -148.25%-597.79K | 27,393.09%5.84M | -100.18%-6.21K | 2.74M | -55.47%4.73M | 28,581.04%1.24M | -100.20%-21.4K |
Net issuance payments of debt | ---- | ---- | -204.73%-1.03M | ---607.11K | ---- | ---- | ---- | --979.34K | --0 | --0 |
Net common stock issuance | --2.26M | --0 | -34.84%2.79M | --0 | --0 | --0 | --2.79M | -63.13%4.28M | 28,603.70%1.24M | -99.74%30K |
Net other financing activities | -1,422.36%-94.51K | 150.27%24.25K | 1,281.58%6.21M | 1,052.91%9.33K | 12,276.89%6.26M | ---6.21K | ---48.24K | 46.43%-525.87K | ---979 | ---51.4K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 36,713.11%2.27M | -99.12%24.25K | 68.49%7.98M | -148.25%-597.79K | 27,393.09%5.84M | -100.18%-6.21K | --2.74M | -55.47%4.73M | 28,581.04%1.24M | -100.20%-21.4K |
Net cash flow | ||||||||||
Beginning cash position | -27.33%2.45M | 177.25%3.9M | -71.31%1.41M | 595.35%6.35M | -31.77%2.11M | 65.36%3.38M | -71.31%1.41M | -10.58%4.9M | -89.31%913.69K | 102.17%3.09M |
Current changes in cash | 148.62%616.97K | -178.46%-1.55M | 171.37%2.54M | -578.93%-2.41M | 292.07%4.25M | -218.82%-1.27M | 167.58%1.97M | -595.90%-3.55M | 114.07%503.18K | -131.52%-2.21M |
Effect of exchange rate changes | -10,753.94%-144.57K | 10,460.21%102.96K | -175.49%-46.04K | -307.90%-47.72K | -101.91%-654 | 106.96%1.36K | -98.32%975 | 188.57%60.99K | 83.30%-11.7K | 832.34%34.25K |
End cash Position | 38.77%2.93M | -27.33%2.45M | 177.25%3.9M | 177.25%3.9M | 595.35%6.35M | -31.77%2.11M | 65.36%3.38M | -71.31%1.41M | -71.31%1.41M | -89.31%913.69K |
Free cash from | -31.14%-1.66M | -103.31%-1.57M | 35.13%-5.44M | -116.93%-1.81M | 27.17%-1.59M | 48.45%-1.26M | 73.51%-772.08K | 24.72%-8.39M | 76.68%-835.35K | 37.56%-2.19M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.